๐ฐ Study Design News
Page 17 - Study Design News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Design. Real-time updates on events, politics, business and more.
November 21, 2022
/PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") will present the efficacy, safety and biomarker findings from the companys...
November 21, 2022
/PRNewswire/ -- BioArctic ABs (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the efficacy, safety and biomarker results from the Phase 3...
November 15, 2022
According to Future Market Insights, the global pediatric clinical trials Market Share is projected to grow steadily at a 5.3% value CAGR, during the forecast period 2022-2032. Earlier in 2021, this market was projected to have a global market valuation worth US$ 15 Billion and is expected to reach a sum of US$ 26.4...
November 10, 2022
DUBLIN--(BUSINESS WIRE)--The "HIV Clinical Trials Market Research Report by Phase, Study Design, Sponsor, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.The Global HIV Clinical Trials Market size was estimated at USD 919.41 million in 2021...
October 22, 2022
This study examines genital HSV-1 transmission and oral and genital viral shedding patterns among persons with first-episode genital HSV-1 infection.
October 11, 2022
BACKGROUND: Using a structured process to develop a self-administered questionnaire provides a robust tool for collecting data that enhances the credibility of the results. Describing this process mitigates any complexity and confusion for the nurse researcher which can be generated by many sources of information that either lack detail or have complex statistical approaches. AIM: To discuss the development of a self-administered questionnaire with a focus on face, content, construct validity an...
October 11, 2022
Background:Multiple vaccines against Covid-19 have passed through phase-3 trials; however, concerns have been raised about alleged excessive similarity of efficacy across age groups for the Sputnik V vaccine.Study Question:How likely are the observed efficacies for all age subgroups to fall within the range of by-age efficacies claimed for the AstraZeneca, Janssen, Moderna, Pfizer, and Sputnik V vaccines, assuming that there is no effect of age on efficacy?Study Design:We performed a simulation ...
October 7, 2022
โData results shared across facial injectables, body contouring and skincare portfolio highlights Allergan Aesthetics continued commitment to advancing...
September 29, 2022
/PRNewswire/ -- The Society to Improve Diagnosis in Medicine (SIDM), revealed today the final line up for SIDM2022, an annual national conference gathering of...
September 26, 2022
Two Late Breaking Clinical Trials Sessions to Feature New Data from REDWOOD-HCM OLE...